The content is available as a PDF (152.5 KB).
. 2022 Jun 1;81:S671. doi: 10.1016/S0302-2838(22)00531-0
How has the COVID-19 pandemic influenced prostate cancer? Tertiary uni-center analysis of diagnosis and treatment times
C Minguez Ojeda
, S Garcia Barreras
, JA López Plaza
, S Arribas Terradilla
, A Dominguez Guitierrez
, G Fernandez Conejo
, E Sanz Mayayo
, A Fraile Poblador
, R Rodriguez Patrón
, FJ Burgos Revilla
C Minguez Ojeda
Find articles by C Minguez Ojeda
S Garcia Barreras
Find articles by S Garcia Barreras
JA López Plaza
Find articles by JA López Plaza
S Arribas Terradilla
Find articles by S Arribas Terradilla
A Dominguez Guitierrez
Find articles by A Dominguez Guitierrez
G Fernandez Conejo
Find articles by G Fernandez Conejo
E Sanz Mayayo
Find articles by E Sanz Mayayo
A Fraile Poblador
Find articles by A Fraile Poblador
R Rodriguez Patrón
Find articles by R Rodriguez Patrón
FJ Burgos Revilla
Find articles by FJ Burgos Revilla
Issue date 2022 Feb.
Copyright © 2022 European Association of Urology. Published by Elsevier B.V. All rights reserved. Published by Elsevier B.V. All rights reserved.
Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
PMCID: PMC9155274